Moreover, there are some trials suggesting that galectin-3 may be regarded as a biomarker in the diagnosis of dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, or left ventricular hypertrophy [9,10,11]. The gene discussed is LGALS3; the disease is dilated cardiomyopathy.